Skip to main content

Advertisement

SpringerLink
Log in

Disseminated Carcinoma Diagnosed by Bone Marrow Biopsy in Patients with Microangiopathic Hemolytic Anemia and Thrombocytopenia: A Report of Two Cases with Gastric Cancer and a Review of the Literature

  • Review Article
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Introduction

Malignancy is often associated with hematological disorders, but rarely is the diagnosis of malignancy secondary to the diagnosis of microangiopathic hemolytic anemia and thrombocytopenia.

Case reports

We report hereby two patients with metastatic gastric carcinoma presenting with microangiopathic hemolytic anemia and thrombocytopenia. Despite chemotherapy and repeated plasmapheresis in one patient, both patients succumbed shortly after the diagnosis of cancer was made.

Conclusion

A review of the literature regarding microangiopathic hemolytic anemia in cancer patients is discussed. In patients suffering from microangiopathic hemolytic anemia and thrombocytopenia, malignancy should be considered as a possible cause. Early diagnosis of malignancy may be critical for determining the patient’s prognosis and potentially avoiding unnecessary overtreatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. George JN. How I treat patients with thrombotic thrombocytopenic purpura–hemolytic uremic syndrome. Blood. 2000;96:1223–9.

    PubMed  CAS  Google Scholar 

  2. George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med. 2006;354:1927–35.

    Article  PubMed  CAS  Google Scholar 

  3. Ruggenenti P, Remuzzi G. Thrombotic microangiopathies. Crit Rev Oncol Hematol. 1991;11:243–65.

    Article  PubMed  CAS  Google Scholar 

  4. Francis KK, Kalyanam N, Terrell DR, Vesely SK, George JN. Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: a report of 10 patients and a systematic review of published cases. Oncologist. 2007;12:11–9.

    Article  PubMed  Google Scholar 

  5. Spoormans I, Altintas S, Van den Brande J, Luijks A, Vermorken JB. Purpura in a patient with disseminated breast cancer: a rapidly progressive cancer-related thrombotic thrombocytopenic purpura. Ann Oncol. 2008;19:1204–7.

    Article  PubMed  CAS  Google Scholar 

  6. Moake JL, Byrnes JJ, Troll JH, Rudy CK, Weinstein MJ, Colannino NM, et al. Abnormal VIII: von Willebrand factor patterns in the plasma of patients with the hemolytic–uremic syndrome. Blood. 1984;64:592–8.

    PubMed  CAS  Google Scholar 

  7. Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 2001;413:488–94.

    Article  PubMed  CAS  Google Scholar 

  8. Hosler GA, Cusumano AM, Hutchins GM. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases. Arch Pathol Lab Med. 2003;127:834–9.

    PubMed  Google Scholar 

  9. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, et al. von Willebrand factor-cleaving protease in thromboticthrombocytopenic purpura and the hemolytic–uremic syndrome. N Engl J Med. 1998;339:1578–84.

    Article  PubMed  CAS  Google Scholar 

  10. Furlan M, Robles R, Solenthaler M, Lammle B. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood. 1998;91:2839–46.

    PubMed  CAS  Google Scholar 

  11. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998;339:1585–94.

    Article  PubMed  CAS  Google Scholar 

  12. Zakarija A, Bennett C. Drug-induced thrombotic microangiopathy. Semin Thromb Hemost. 2005;31:681–90.

    Article  PubMed  CAS  Google Scholar 

  13. Zupancic M, Shah PC, Shah-Khan F. Gemcitabine-associated thrombotic thrombocytopenic purpura. Lancet Oncol. 2007;8:634–41.

    Article  PubMed  CAS  Google Scholar 

  14. KremerHovinga JA, Vesely SK, Terrell DR, Lammle B, George JN. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2010;115:1500–11.

    Article  Google Scholar 

  15. Aksoy M, Erdem S, Tahsinglu M, Dincol G, Debbag F. Microangiopathic hemolytic anemia due to adenocarcinoma of the stomach. New Istanbul Contrib Clin Sci. 1975;11:103–7.

    PubMed  CAS  Google Scholar 

  16. Podzamczer D, Carreras L, Condom E, Baucells JM, Vidaller A. Microangiopathic hemolytic anemia associated with pulmonary adenocarcinoma. JAMA. 1985;254:2554–5.

    Article  PubMed  CAS  Google Scholar 

  17. Eugene M, Deray G, Cacoub P, Achour A, Baumelou A. Hemolytic uremic syndrome and prostatic adenocarcinoma. Clin Nephrol. 1987;27:46.

    PubMed  CAS  Google Scholar 

  18. Sill H, Hofler G, Kaufmann P, Horina J, Spuller E, Kleinert R, et al. Angiotropic large cell lymphoma presenting as thrombotic microangiopathy (thrombotic thrombocytopenic purpura). Cancer. 1995;75:1167–9.

    Article  PubMed  CAS  Google Scholar 

  19. Kouides PA, Phatak PD, Cramer SF. Fatal thrombotic thrombocytopenia purpura (TTP) presenting concurrently with metastatic multiple endocrine neoplasia (MEN) type I. Hematopathol Mol Hematol. 1996;10:161–70.

    PubMed  CAS  Google Scholar 

  20. Gonzalez N, Rios E, Martin-Noya A, Rodríguez JM. Thrombotic thrombocytopenic purpura and bone marrow necrosis as a complication of gastric neoplasm. Haematologia. 2002;87:ECR01.

    Google Scholar 

  21. Pirrotta MT, Bucalossi A, Forconi F, Bocchia M, Mazzotta S, Sammassimo S, et al. Thrombotic thrombocytopenic purpura secondary to an occult adenocarcinoma. Oncologist. 2005;10:299–300.

    Article  PubMed  Google Scholar 

  22. Murgo AJ. Thrombotic microangiopathy in the cancer patients including those induced by chemotherapeutic agents. Semin Hematol. 1987;24:161–77.

    PubMed  CAS  Google Scholar 

  23. Lesesne JB, Rothschild N, Erickson B, Korec S, Sisk R, Keller J, et al. Cancer-Associated hemolytic–uremic syndrome: analysis of 85 cases from a national registry. J Clin Oncol. 1989;7:781–9.

    PubMed  CAS  Google Scholar 

  24. Levandovsky M, Harvey D, Lara P, Wun T. Thrombotic thrombocytopenic purpura–hemolytic uremic syndrome (TTP–HUS): a 24-year clinical experience with 178 patients. J Hematol Oncol. 2008;1:23.

    Article  PubMed  Google Scholar 

  25. Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med. 1991;325:398–403.

    Article  PubMed  CAS  Google Scholar 

  26. Kwaan HC, Soff GA. Management of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Semin Hematol. 1997;34:159–66.

    PubMed  CAS  Google Scholar 

  27. Lara Jr PN, Coe TL, Zhou H, Fernando L, Holland PV, Wun T. Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura–hemolytic uremic syndrome. Am J Med. 1999;107:573–9.

    Article  PubMed  Google Scholar 

  28. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med. 1991;325:393–7.

    Article  PubMed  CAS  Google Scholar 

  29. Vesely SK, George JN, Rath W. Long term clinical outcome of thrombotic thrombocytopenic purpura–hemolytic uremic syndrome (TTP–HUS) among different patient groups. Blood. 1999;94:15a.

    Google Scholar 

  30. Vasko R, Koziolek M, Fuzesi L, Konig F, Strutz F, Muller GA. Fulminant plasmapheresis–refractory microangiopathy associated with advanced gastric cancer. Ther Apher Dial. 2010;14:222–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Oncology, Rambam Health Care Campus and Faculty of Medicine, Technion-Israel Institute of Technology, POB 9602, Haifa, 31096, Israel

    Orit Kaidar-Person, Haitam Nasrallah, Nissim Haim & Gil Bar-Sela

  2. Department of Hematology, Rambam Health Care Campus and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

    Eldad J. Dann

Authors
  1. Orit Kaidar-Person
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Haitam Nasrallah
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nissim Haim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eldad J. Dann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gil Bar-Sela
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gil Bar-Sela.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaidar-Person, O., Nasrallah, H., Haim, N. et al. Disseminated Carcinoma Diagnosed by Bone Marrow Biopsy in Patients with Microangiopathic Hemolytic Anemia and Thrombocytopenia: A Report of Two Cases with Gastric Cancer and a Review of the Literature. J Gastrointest Canc 42, 123–126 (2011). https://doi.org/10.1007/s12029-010-9204-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-010-9204-6

Keywords

Search

Navigation